PROVIDUS Trademark

Trademark Overview


On Wednesday, July 30, 2025, a trademark application was filed for PROVIDUS with the United States Patent and Trademark Office. The USPTO has given the PROVIDUS trademark a serial number of 99310861. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 30, 2025. This trademark is owned by ITALFARMACO S.P.A.. The PROVIDUS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Health data collection and medical record analysis for scientific studies; Monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies

Scientific and technological services; Scientific services and research related to the same; Scientific services and design related to the same; Platform as a service [PAAS] comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; Research services, design and development of instruments for control and diagnostics; Scientific research; Electronic data storage; Technical writing, namely medical writing services for the development of medical protocols, clinical study reports, researcher pamphlets, safety reports, informed consent forms, meeting summaries, posters, manuscripts, study diagrams, manuals, and literature reviews; Design, implementation and management of clinical and observational study protocols; Statistical analysis and interpretation of scientific data; Electronic storage of files and documents; computer diagnostic services, computer analysis services; providing online non-downl...
providus

General Information


Serial Number99310861
Word MarkPROVIDUS
Filing DateWednesday, July 30, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, July 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "PROVIDUS" in stylized blue font followed by a diagonal blue line, a diagonal teal line, a diagonal white line, a diagonal sage green line, a diagonal dark green line, and a diagonal medium green line.
Indication of Colors claimedThe color(s) blue, teal, white, sage green, dark green, medium green is/are claimed as a feature of the mark.
Goods and ServicesHealth data collection and medical record analysis for scientific studies; Monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies
Goods and ServicesScientific and technological services; Scientific services and research related to the same; Scientific services and design related to the same; Platform as a service [PAAS] comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; Research services, design and development of instruments for control and diagnostics; Scientific research; Electronic data storage; Technical writing, namely medical writing services for the development of medical protocols, clinical study reports, researcher pamphlets, safety reports, informed consent forms, meeting summaries, posters, manuscripts, study diagrams, manuals, and literature reviews; Design, implementation and management of clinical and observational study protocols; Statistical analysis and interpretation of scientific data; Electronic storage of files and documents; computer diagnostic services, computer analysis services; providing online non-downloadable software featuring clinical study and clinical trial management system tools via a website; providing online non-downloadable software featuring study management files; programming of software for study management files; electronic storage services for archiving temporary files throughout the clinical study lifecycle; scientific research, namely programming of software for biostatistics, development of protocols for sample size and statistical power calculations, randomization plans, statistical analysis plans; programming of software for validation in a statistical analysis system; providing online non-downloadable software enabling interpretation and reporting of data for clinical trial reports and publications; product development for others; scientific research, namely intermediate analysis for early decision making; providing online non-downloadable software featuring database and data lists ready for a New Drug Application (NDA), regulatory submission-compliant data files, study data tabulation and data on model regulatory submission standards; medical research and development for new products for others in the field of medical surveillance and safety plans, ongoing oversight of patient-level studies and review of safety data, interpretation of study protocol, consultation on potential safety and medical issues and 24/7 medical surveillance coverage; drug development; drug discovery of adverse events from clinical trials, development of safety update reports and other aggregate reports, development of management safety plans and medical surveillance plans; quality testing of clinical trial's documentation, for example, standard operating procedures (sops) and work instructions, internal system reviews, site audits, provider evaluations; Medical research in the following areas: pharmacology namely simulation, dose selection and optimization, biomarker and endpoint selection, study design optimization, population pharmacokinetic and pharmacodynamic modeling, exposure response modeling; Medical research; Information related to scientific and medical research in the area of clinical trials, namely the design of clinical trials and outcome measures for studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Conducting clinical trials for third parties studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Custom computer programming related to the following fields: image training and integration into computer systems of suitability data with interactive response technology (IRT); design and development of computer databases for the collection, storage, management, analysis and validation of data for use in the medical and pharmaceutical fields; electronic storage services for archiving presentations; Providing information on clinical studies via an interactive website

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code042
First Use Anywhere DateFriday, June 20, 2025
First Use In Commerce DateFriday, June 20, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code044
First Use Anywhere DateFriday, June 20, 2025
First Use In Commerce DateFriday, June 20, 2025

Trademark Owner History


Party NameITALFARMACO S.P.A.
Party Type10 - Original Applicant
Legal Entity Type35 - NOT AVAILABLE
AddressMilan (MI) 20126
IT

Trademark Events


Event DateEvent Description
Wednesday, July 30, 2025NEW APPLICATION ENTERED
Wednesday, July 30, 2025APPLICATION FILING RECEIPT MAILED